Well done to management. Great positive step for the company!!
PAA can now move into the trials in an excellent position.
BRI announcement will be excellent - obvious.
As with my lunch with Tony Locantro earlier this year, just a reminder,
* PAA is undervalued,
* MPL is showing promise, as we are seeing in the reformulation
* Big opportunity for biotech funds and institutions to invest, as we see here today
* Massive inflection points are in the wings.
* Epichems expansion is nearly complete. Don't quote me on this.
* Epichems forecast income this financial year of in excess of 4 Million...
* My estimate of the burn rate will rise initially because trials, but will settle down and be overall will be less than 250k per quarter.
* And most importantly, MPL reformulated, more potent etc, ready for human and canine trials.
* MPL ready to take to the world market to treat canines.
And the share price - soooo undervalued.
When will the market awake to this golden child?
As always
Best
MM
Well done to management. Great positive step for the company!!...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.010(6.25%) |
Mkt cap ! $82.65M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 17.0¢ | 15.5¢ | $145.3K | 876.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 38307 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 302337 | 3 |
View Market Depth
| Last trade - 15.51pm 23/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |